Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 1 examiners • 0 of 2 (0%) have an AI response strategy ready
Rks Global Pte. Ltd. manages a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. There are 2 pending office actions currently in the prosecution pipeline. Both of these actions are assigned to 1 distinct examiner and are located within 1 distinct art unit. The busiest examiner for the portfolio is PHAN, DOAN THI-THUC, who is handling 2 pending office actions. This figure matches the total number of pending actions for the company.
Because all pending matters are concentrated under 1 distinct examiner, the prosecution path is centralized. This means the outcomes for the 2 pending office actions are subject to the review standards of PHAN, DOAN THI-THUC. For a practitioner, this concentration in 1 distinct art unit indicates that the technical subject matter is being evaluated within one group. The presence of 2 pending office actions with a single individual suggests a technical dialogue between the company and the examiner. This data provides a point of contact for the company's current legal interactions at the patent office. The results for the portfolio are tied to the examination patterns of the examiner involved.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PHAN, DOAN THI-THUC | 2 | 42.7% | +47.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18477724 | DOSAGE IN FILM PACKAGE FORM, A FILM COMPOSITION AND A PROCESS FOR PREPARATION THEREOF | PHAN, DOAN THI-THUC | 4d overdue |
| 17052864 | A DOSAGE IN FILM PACKAGE FORM, A FILM COMPOSITION AND A PROCESS FOR PREPARATION THEREOF | PHAN, DOAN THI-THUC | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18477724 | DOSAGE IN FILM PACKAGE FORM, A FILM COMPOSITION AND A PROCESS FOR PREPARATION THEREOF | PHAN, DOAN THI-THUC | 4d overdue |
| 17052864 | A DOSAGE IN FILM PACKAGE FORM, A FILM COMPOSITION AND A PROCESS FOR PREPARATION THEREOF | PHAN, DOAN THI-THUC | — |
| Art Unit | Apps |
|---|---|
| 1613 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18477724 | DOSAGE IN FILM PACKAGE FORM, A FILM COMPOSITION AND A PROCESS FOR PREPARATION THEREOF | PHAN, DOAN THI-THUC | 1613 | §103§112 | Final Rejection | 4d overdue | Pending | Sep 29, 2023 |
| 17052864 | A DOSAGE IN FILM PACKAGE FORM, A FILM COMPOSITION AND A PROCESS FOR PREPARATION THEREOF | PHAN, DOAN THI-THUC | 1613 | §103§112 | Non-Final OA | — | Pending | Nov 04, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial